This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301–12.
Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54(21):1924–31.
Conflict of interest
Dr. West has acted as a consultant for Abbott Vascular. Dr. Hoole has acted as a consultant for St. Jude Medical and Abbott Vascular. All other authors have no conflicts of interest to declare.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Giblett, J.P., Brown, A.J., Hoole, S.P. et al. Early disarticulation of a bioresorbable vascular scaffold: an underreported consequence of repeat imaging. Cardiovasc Interv and Ther 33, 175–177 (2018) doi:10.1007/s12928-017-0464-y